Skocz do pozycji: 1.

Tytuł:

#corticophobia: a review on online misinformation related to topical steroids.

Autorzy:

Finnegan P; Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
Murphy M; Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.; Department of Medicine, University College Cork, Cork, Ireland.
O'Connor C; Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.; Department of Medicine, University College Cork, Cork, Ireland.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Feb 02; Vol. 48 (2), pp. 112-115.

Typ publikacji:

Review; Journal Article

MeSH Terms:

Dermatitis, Atopic*/drug therapy
Skin Diseases*/drug therapy
Dermatologic Agents*/therapeutic use
Humans ; Adrenal Cortex Hormones/adverse effects ; Glucocorticoids ; Steroids

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 2.

Tytuł:

How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals.

Autorzy:

Moledina Z; Department of Dermatology, Nottingham University Hospitals NHS Trust, UK.
McPhee M; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, UK.
Ravenscroft JC; Department of Paediatric Dermatology, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, UK.
Healy E; Department of Dermatopharmacology, Faculty of Medicine, University of Southampton, UK.
Radley K; Department of Clinical, Pharmaceutical and Biological Science, School of Life and Medical Sciences, University of Hertfordshire, UK.
Thomas KS; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, UK.
Burden-Teh E; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, UK.

Pokaż więcej

Corporate Authors:

Acne-ID Trial Development Team

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Jan 20; Vol. 48 (1), pp. 20-23.

Typ publikacji:

Journal Article

MeSH Terms:

Dermatologic Agents*/therapeutic use
Dermatology*
Acne Vulgaris*/drug therapy
Humans ; Isotretinoin/therapeutic use ; Treatment Outcome ; Administration, Oral ; United Kingdom

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 3.

Tytuł:

Regular support provided by dermatological nurses improves outcomes in patients with psoriasis treated with topical drugs: a randomized controlled trial.

Autorzy:

Svendsen MT; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Dermatology and Allergy Centre, Odense University Hospital, Denmark.; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Feldman SR; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Dermatology and Allergy Centre, Odense University Hospital, Denmark.; Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Mejldal A; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Möller S; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Kongstad LP; Danish Centre for Health Economics (DaCHE), University of Southern Denmark, Odense, Denmark.
Andersen KE; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Dec; Vol. 47 (12), pp. 2208-2221. Date of Electronic Publication: 2022 Oct 25.

Typ publikacji:

Randomized Controlled Trial; Journal Article

MeSH Terms:

Dermatologic Agents*/therapeutic use
Psoriasis*/drug therapy
Humans ; Patient Compliance ; Quality of Life ; Severity of Illness Index ; Treatment Outcome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 4.

Tytuł:

Acupuncture and osteopathic medicine for atopic dermatitis: a three-armed, randomized controlled explorative clinical trial.

Autorzy:

Rotter G; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ahnert MW; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Geue AV; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Icke K; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Binting S; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Tissen-Diabaté T; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Roll S; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ortiz M; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Reinhold T; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Kass B; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Staab D; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Pfab F; Medzentrum Residenz, Munich, Germany.
Willich SN; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Brinkhaus B; Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Dec; Vol. 47 (12), pp. 2166-2175. Date of Electronic Publication: 2022 Oct 27.

Typ publikacji:

Randomized Controlled Trial; Journal Article

MeSH Terms:

Dermatitis, Atopic*/drug therapy
Osteopathic Medicine*
Dermatologic Agents*/therapeutic use
Acupuncture Therapy*
Male ; Adult ; Humans ; Female ; Young Adult ; Treatment Outcome ; Pruritus/therapy ; Pruritus/chemically induced ; Severity of Illness Index ; Adrenal Cortex Hormones/therapeutic use ; Double-Blind Method

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 5.

Tytuł:

Prescribing and using vitiligo treatments: lessons from a nested process evaluation within the HI-Light vitiligo randomized controlled trial.

Autorzy:

Leighton P; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Chalmers JR; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Batchelor JM; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Rogers A; Department of Medical Physics and Clinical Engineering, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Akram P; Department of Medical Physics and Clinical Engineering, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Haines RH; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
Meakin GD; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
White J; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
Ravenscroft JC; Department of Paediatric Dermatology, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Sach TH; Norwich Medical School, University of East Anglia, Norwich, UK.
Santer M; Primary Care and Population Sciences, University of Southampton, Southampton, UK.
Whitton ME; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Eleftheriadou V; Walsall Manor Hospital, Walsall, UK.
Thomas KS; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Aug; Vol. 47 (8), pp. 1480-1489. Date of Electronic Publication: 2022 May 30.

Typ publikacji:

Journal Article; Randomized Controlled Trial

MeSH Terms:

Dermatologic Agents*/therapeutic use
Ultraviolet Therapy*/methods
Vitiligo*/drug therapy
Humans ; Surveys and Questionnaires ; Treatment Outcome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 6.

Tytuł:

Topical steroid withdrawal through the lens of social media.

Autorzy:

Bowe S; Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
Masterson S; Medical School, University of Limerick, Limerick, Ireland.
Murray G; Department of Dermatology, Beaumont Hospital, Dublin, Ireland.
Haugh I; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Aug; Vol. 47 (8), pp. 1554-1557. Date of Electronic Publication: 2022 May 10.

Typ publikacji:

Journal Article

MeSH Terms:

Dermatologic Agents*/adverse effects
Eczema*/chemically induced
Social Media*
Glucocorticoids/adverse effects ; Humans ; Retrospective Studies ; Steroids

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 7.

Tytuł:

The efficacy and safety of pimecrolimus 1% cream vs. sertaconazole 2% cream in the treatment of patients with facial seborrhoeic dermatitis: a randomized blinded trial.

Autorzy:

Azizzadeh M; Clinical Research Development Unit (CRDU), Kowsar Hospital, Semnan University of Medical Sciences, Semnan, Iran.
Pahlevan D; Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran.
Bagheri B; Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran.; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 May; Vol. 47 (5), pp. 926-931. Date of Electronic Publication: 2022 Jan 25.

Typ publikacji:

Journal Article; Randomized Controlled Trial

MeSH Terms:

Dermatitis, Seborrheic*/drug therapy
Dermatologic Agents*/therapeutic use
Double-Blind Method ; Emollients/therapeutic use ; Humans ; Imidazoles ; Tacrolimus/adverse effects ; Tacrolimus/analogs & derivatives ; Thiophenes ; Treatment Outcome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 8.

Tytuł:

Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: a 36-month follow-up study.

Autorzy:

Salava A; Helsinki University Hospital, Skin and Allergy Hospital, Helsinki, Finland.
Perälä M; Helsinki University Hospital, Skin and Allergy Hospital, Helsinki, Finland.
Pelkonen A; Helsinki University Hospital, Skin and Allergy Hospital, Helsinki, Finland.
Mäkelä M; Helsinki University Hospital, Skin and Allergy Hospital, Helsinki, Finland.
Remitz A; Helsinki University Hospital, Skin and Allergy Hospital, Helsinki, Finland.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 May; Vol. 47 (5), pp. 889-902. Date of Electronic Publication: 2022 Jan 13.

Typ publikacji:

Journal Article

MeSH Terms:

Dermatitis, Atopic*/drug therapy
Dermatitis, Atopic*/pathology
Dermatologic Agents*/therapeutic use
Administration, Topical ; Child ; Child, Preschool ; Follow-Up Studies ; Glucocorticoids/therapeutic use ; Humans ; Immunosuppressive Agents/adverse effects ; Infant ; Ointments/therapeutic use ; Tacrolimus/adverse effects ; Treatment Outcome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 9.

Tytuł:

First use of the Adolescent Depression Rating Scale (ADRS) in the management of young people with severe acne treated with isotretinoin: a pilot study of an active monitoring of depressive disorders by dermatologists.

Autorzy:

Hefez L; Department of Dermatology, Grand Hôpital Est Francilien, Jossigny, France.
Micallef J; Service de Pharmacologie Clinique et Pharmacovigilance, Pharmacometry and Pharmacoepidemiology, Institut de Neurosciences des Systèmes, APHM/INSERM/Aix Marseille University, Marseille, France.
Revah-Levy A; Department of Adolescent Psychiatry, Centre Hospitalier Victor Dupouy, Argenteuil, France.; ECSTRRA team, Statistic And Epidemiological Research Centre Sorbonne Paris Cité (CRESS), INSERM U1153, Université de Paris, Paris, France.
Falissard B; INSERM U669, Paris-Sud 11 University, APHP, Villejuif, France, Paris, France.
Jouve E; Service de Pharmacologie Clinique et Pharmacovigilance, Pharmacometry and Pharmacoepidemiology, Institut de Neurosciences des Systèmes, APHM/INSERM/Aix Marseille University, Marseille, France.
Dreno B; Onco-Dermatology Department, CHU Nantes, CRCINA, Nantes University, Nantes, France.
Chosidow O; Department of Dermatology, APHP, Hôpital Henri-Mondor, Faculté de Santé, Paris-Est, Créteil, France.; Research Group Dynamic, EA7380, Faculté de Santé de Créteil, École Nationale Vétérinaire d'Alfort, USC ANSES, Université Paris-Est Créteil, Créteil, France.; Centre de Preuves de la Société Française de Dermatologie, Paris, France.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Apr; Vol. 47 (4), pp. 709-716. Date of Electronic Publication: 2021 Dec 27.

Typ publikacji:

Journal Article; Multicenter Study

MeSH Terms:

Acne Vulgaris*/drug therapy
Acne Vulgaris*/psychology
Depressive Disorder*/diagnosis
Depressive Disorder*/drug therapy
Depressive Disorder*/etiology
Dermatologic Agents*/adverse effects
Dermatologic Agents*/therapeutic use
Adolescent ; Depression/diagnosis ; Depression/drug therapy ; Depression/etiology ; Dermatologists ; Humans ; Isotretinoin/adverse effects ; Isotretinoin/therapeutic use ; Pilot Projects ; Prospective Studies

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 10.

Tytuł:

Cysteamine as a topical management option for melasma.

Autorzy:

Hira SK; Department of Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Nalluri R; Department of Dermatology, Manchester University NHS Foundation Trust Varna pigmentation, Manchester, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 646-647. Date of Electronic Publication: 2021 Nov 23.

Typ publikacji:

Journal Article

MeSH Terms:

Cysteamine/*administration & dosage
Dermatologic Agents/*administration & dosage
Melanosis/*drug therapy
Administration, Topical ; Humans ; Intention to Treat Analysis ; Skin Cream ; Treatment Outcome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 11.

Tytuł:

Successful treatment of severe recalcitrant vernal keratoconjunctivitis and atopic dermatitis associated with elevated IgE levels with omalizumab.

Autorzy:

Zengarini C; Dermatology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.
Roda M; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Schiavi C; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Bruni F; Dermatology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.
Bardazzi F; Dermatology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.
Bellusci C; Ophthalmology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Raone B; Dermatology Unit, IRCCS, Policlinico Sant'Orsola Hospital, Bologna, Italy.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 604-606. Date of Electronic Publication: 2021 Dec 16.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Anti-Allergic Agents/*therapeutic use
Dermatitis, Atopic/*complications
Dermatitis, Atopic/*drug therapy
Dermatologic Agents/*therapeutic use
Keratoconjunctivitis/*complications
Keratoconjunctivitis/*drug therapy
Omalizumab/*therapeutic use
Adolescent ; Dermatitis, Atopic/immunology ; Dermatitis, Atopic/pathology ; Hand Dermatoses/complications ; Hand Dermatoses/drug therapy ; Hand Dermatoses/immunology ; Humans ; Immunoglobulin E/blood ; Keratoconjunctivitis/immunology ; Keratoconjunctivitis/pathology ; Male

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 12.

Tytuł:

Acute spondyloarthritis developing during successful treatment with dupilumab for severe atopic dermatitis.

Autorzy:

Raimondo A; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy.
Guglielmi G; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy.
Marino C; S. Giovanni di Dio e Ruggi D'Aragona University Hospital, PO Santa Maria Incoronata Dell'Olmo, Cava dè Tirreni, Salerno, Italy.
Ligrone L; S. Giovanni di Dio e Ruggi D'Aragona University Hospital, PO Santa Maria Incoronata Dell'Olmo, Cava dè Tirreni, Salerno, Italy.
Lembo S; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 592-593. Date of Electronic Publication: 2021 Dec 09.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Antibodies, Monoclonal, Humanized/*adverse effects
Dermatitis, Atopic/*drug therapy
Dermatologic Agents/*adverse effects
Osteoarthritis, Spine/*chemically induced
Adult ; Azetidines/therapeutic use ; Dermatologic Agents/therapeutic use ; Humans ; Janus Kinase 1/antagonists & inhibitors ; Janus Kinase 2/antagonists & inhibitors ; Male ; Osteoarthritis, Spine/diagnosis ; Osteoarthritis, Spine/drug therapy ; Purines/therapeutic use ; Pyrazoles/therapeutic use ; Sulfonamides/therapeutic use

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 13.

Tytuł:

A detailed regimen of isotretinoin for the successful treatment of severe keratosis pilaris.

Autorzy:

Kirchner A; University of Illinois College of Medicine, Chicago, IL, USA.
Hoyer S; Department of Dermatology, University of Illinois College of Medicine, Chicago, IL, USA.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 619-621. Date of Electronic Publication: 2021 Dec 16.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Abnormalities, Multiple/*drug therapy
Darier Disease/*drug therapy
Dermatologic Agents/*therapeutic use
Eyebrows/*abnormalities
Isotretinoin/*therapeutic use
Abnormalities, Multiple/pathology ; Adolescent ; Darier Disease/pathology ; Dermatologic Agents/administration & dosage ; Drug Administration Schedule ; Eyebrows/pathology ; Female ; Humans ; Isotretinoin/administration & dosage ; Treatment Outcome

SCR Disease Name:

Burnett Schwartz Berberian syndrome

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 14.

Tytuł:

Topical Cyperus rotundus essential oil for treatment of axillary hyperpigmentation: a randomized, double-blind, active- and placebo-controlled study.

Autorzy:

Mohammed GF; Department of Dermatology, Venereology and Sexology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 534-541. Date of Electronic Publication: 2021 Nov 24.

Typ publikacji:

Journal Article; Randomized Controlled Trial

MeSH Terms:

Axilla*/pathology
Cyperus*
Anti-Inflammatory Agents/*therapeutic use
Dermatologic Agents/*therapeutic use
Hyperpigmentation/*drug therapy
Oils, Volatile/*therapeutic use
Administration, Topical ; Adult ; Anti-Inflammatory Agents/adverse effects ; Anti-Inflammatory Agents/economics ; Colorimetry ; Cost-Benefit Analysis ; Dermatologic Agents/adverse effects ; Dermatologic Agents/economics ; Double-Blind Method ; Female ; Hair/drug effects ; Hair/growth & development ; Humans ; Hydroquinones/therapeutic use ; Hyperpigmentation/pathology ; Oils, Volatile/adverse effects ; Oils, Volatile/economics ; Skin Cream ; Young Adult

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 15.

Tytuł:

Risankizumab-induced paradoxical pustular psoriasis.

Autorzy:

McFeely O; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
Pender E; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
Victory L; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
Almutlaq H; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.; Department of Dermatology, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Storan E; Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 616-617. Date of Electronic Publication: 2021 Dec 10.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Antibodies, Monoclonal/*adverse effects
Dermatologic Agents/*adverse effects
Interleukin-23 Subunit p19/*antagonists & inhibitors
Psoriasis/*chemically induced
Cyclosporine/therapeutic use ; Dermatologic Agents/therapeutic use ; Disease Progression ; Female ; Humans ; Middle Aged ; Psoriasis/drug therapy ; Psoriasis/pathology

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 16.

Tytuł:

Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.

Autorzy:

Ruggiero A; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Cinelli E; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Ocampo Garza SS; Department of Dermatology, University Hospital Dr José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Camela E; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Megna M; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 561-567. Date of Electronic Publication: 2021 Nov 17.

Typ publikacji:

Journal Article

MeSH Terms:

Antibodies, Monoclonal/*therapeutic use
Antibodies, Monoclonal, Humanized/*therapeutic use
Biological Products/*therapeutic use
Dermatologic Agents/*therapeutic use
Interleukin-23 Subunit p19/*antagonists & inhibitors
Psoriasis/*drug therapy
Age of Onset ; Aged ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized/adverse effects ; Biological Products/adverse effects ; Dermatologic Agents/adverse effects ; Female ; Humans ; Male ; Psoriasis/immunology ; Remission Induction ; Retrospective Studies

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 17.

Tytuł:

Successful use of tofacitinib in epidermolysis bullosa pruriginosa.

Autorzy:

Chen KJ; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Fang S; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ye Q; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jia M; Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 598-600. Date of Electronic Publication: 2021 Nov 28.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Dermatologic Agents/*therapeutic use
Epidermolysis Bullosa Dystrophica/*drug therapy
Janus Kinase Inhibitors/*therapeutic use
Piperidines/*therapeutic use
Pyrimidines/*therapeutic use
Adult ; Epidermolysis Bullosa Dystrophica/complications ; Epidermolysis Bullosa Dystrophica/pathology ; Female ; Humans ; Pruritus/drug therapy ; Pruritus/etiology

SCR Disease Name:

Epidermolysis Bullosa Pruriginosa

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 18.

Tytuł:

Racial representation in clinical trials for dermatological new molecular entities.

Autorzy:

Ha MV; Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Wong C; Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Feb; Vol. 47 (2), pp. 386-388. Date of Electronic Publication: 2021 Sep 07.

Typ publikacji:

Journal Article

MeSH Terms:

Clinical Trials as Topic*
Dermatologic Agents*
Patient Selection*
Black or African American/*statistics & numerical data
Drug Approval/*statistics & numerical data
Dermatology ; Ethnic and Racial Minorities/statistics & numerical data ; Humans ; Skin Diseases/drug therapy ; Skin Diseases/ethnology ; United States ; United States Food and Drug Administration

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 19.

Tytuł:

Successful use of dupilumab for the treatment of atopic dermatitis on the genitals, a neglected anatomical site.

Autorzy:

Paolino G; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Sernicola A; Dermatology Clinic, Sapienza University of Rome, Rome, Italy.
Di Nicola MR; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Foti A; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Brianti P; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Vaira F; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Grieco T; Dermatology Clinic, Sapienza University of Rome, Rome, Italy.
Mercuri SR; Dermatology Unit, IRCCS San Raffaele Hospital, Milan, Italy.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jan; Vol. 47 (1), pp. 176-178. Date of Electronic Publication: 2021 Aug 30.

Typ publikacji:

Letter

MeSH Terms:

Antibodies, Monoclonal, Humanized/*therapeutic use
Dermatitis, Atopic/*drug therapy
Dermatitis, Atopic/*pathology
Dermatologic Agents/*therapeutic use
Genitalia, Female/*pathology
Genitalia, Male/*pathology
Interleukin-4 Receptor alpha Subunit/*antagonists & inhibitors
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Young Adult

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 20.

Tytuł:

Topical treatment samples: plastic, recycling and sustainability.

Autorzy:

Kamp E; Dermatology Department, University Hospitals Sussex, Brighton, UK.
Musbahi E; Dermatology Department, University Hospitals Sussex, Brighton, UK.
Gupta P; Dermatology Department, University Hospitals Sussex, Brighton, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jan; Vol. 47 (1), pp. 186. Date of Electronic Publication: 2021 Sep 07.

Typ publikacji:

Letter

MeSH Terms:

Conservation of Natural Resources*
Dermatologic Agents*
Drug Packaging*
Plastics*
Recycling*

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 21.

Tytuł:

Analysis of US Food and Drug Administration Warning Letters within dermatological care products.

Autorzy:

Gorrepati PL; Department of Dermatology, Massachusetts General Hospital of Harvard Medical School, Boston, MA, USA.
Smith GP; Department of Dermatology, Massachusetts General Hospital of Harvard Medical School, Boston, MA, USA.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jan; Vol. 47 (1), pp. 194-196. Date of Electronic Publication: 2021 Sep 22.

Typ publikacji:

Letter

MeSH Terms:

Dermatologic Agents*
Drug Labeling*
United States Food and Drug Administration*
Humans ; United States

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 22.

Tytuł:

How safe and effective is prescribing oral isotretinoin to treat acne in patients on renal dialysis? A systematic review.

Autorzy:

Gan A; Dermatology Department, St Mary's Hospital, Imperial College NHS Healthcare Trust, London, UK.
Therianou A; Dermatology Department, St Mary's Hospital, Imperial College NHS Healthcare Trust, London, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jan; Vol. 47 (1), pp. 16-23. Date of Electronic Publication: 2021 Oct 10.

Typ publikacji:

Journal Article; Systematic Review

MeSH Terms:

Renal Dialysis*
Acne Vulgaris/*drug therapy
Dermatologic Agents/*administration & dosage
Isotretinoin/*administration & dosage
Administration, Oral ; Dermatologic Agents/adverse effects ; Humans ; Isotretinoin/adverse effects ; Treatment Outcome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 23.

Tytuł:

Delaying dermatological procedural interventions in the context of isotretinoin use: is there a shift in the consensus?

Autorzy:

Raza SA; University of Birmingham Medical School, College of Medical and Dental Sciences, Birmingham, UK.
Ali FR; Department of Dermatology, Waters Green Medical Centre, Mid Cheshire Hospitals NHS Foundation Trust, Cheshire, UK.; St John's Institute of Dermatology, London, UK.
Al-Niaimi F; Department of Dermatology, University of Aalborg, Aalborg, Denmark.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jan; Vol. 47 (1), pp. 240-241. Date of Electronic Publication: 2021 Sep 21.

Typ publikacji:

Journal Article; Comment

MeSH Terms:

Acne Vulgaris*/drug therapy
Dermatologic Agents*/adverse effects
Consensus ; Humans ; Isotretinoin/adverse effects

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 24.

Tytuł:

Persistent facial discoid dermatosis successfully treated with topical calcipotriol.

Autorzy:

Amarnani R; Department of, Dermatology, University College London Hospital NHS Foundation Trust, London, UK.
Hughes S; Department of, Histopathology, University College London Hospital NHS Foundation Trust, London, UK.
Morris-Jones R; Department of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Kanwar AJ; Dr A.J. Kanwar Clinic, New Delhi, India.
Bunker CB; Department of, Dermatology, University College London Hospital NHS Foundation Trust, London, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jan; Vol. 47 (1), pp. 229-231. Date of Electronic Publication: 2021 Oct 14.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Calcitriol/*analogs & derivatives
Dermatologic Agents/*administration & dosage
Facial Dermatoses/*drug therapy
Administration, Topical ; Calcitriol/administration & dosage ; Facial Dermatoses/pathology ; Female ; Humans ; Middle Aged ; Remission Induction

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 25.

Tytuł:

Anakinra for recalcitrant pyoderma gangrenosum.

Autorzy:

O'Connor C; Department of Dermatology, University Hospital Waterford, Waterford, Ireland.; Department of Medicine, University College Cork, Cork, Ireland.
Gallagher C; Department of Dermatology, University Hospital Waterford, Waterford, Ireland.
Hollywood A; Department of Dermatology, University Hospital Waterford, Waterford, Ireland.
Paul L; Department of Dermatology, University Hospital Waterford, Waterford, Ireland.
O'Connell M; Department of Dermatology, University Hospital Waterford, Waterford, Ireland.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Dec; Vol. 46 (8), pp. 1558-1560. Date of Electronic Publication: 2021 Aug 18.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Dermatologic Agents/*therapeutic use
Interleukin 1 Receptor Antagonist Protein/*therapeutic use
Pyoderma Gangrenosum/*drug therapy
Aged ; Antiphospholipid Syndrome/complications ; Arthritis, Rheumatoid/complications ; Dermatologic Agents/adverse effects ; Dyslipidemias/complications ; Female ; Humans ; Hypertension/complications ; Interleukin 1 Receptor Antagonist Protein/adverse effects ; Middle Aged ; Obesity/complications ; Peripheral Vascular Diseases/complications ; Pyoderma Gangrenosum/complications ; Renal Insufficiency, Chronic/complications

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 26.

Tytuł:

Ixekizumab-induced paradoxical pustular reaction successfully treated with guselkumab.

Autorzy:

Hlaca N; Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.; Medical Faculty, University of Rijeka, Rijeka, Croatia.
Zagar T; Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Kastelan M; Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.; Medical Faculty, University of Rijeka, Rijeka, Croatia.
Brajac I; Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.; Medical Faculty, University of Rijeka, Rijeka, Croatia.
Prpic-Massari L; Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.; Medical Faculty, University of Rijeka, Rijeka, Croatia.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Dec; Vol. 46 (8), pp. 1572-1573. Date of Electronic Publication: 2021 Jun 24.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Antibodies, Monoclonal, Humanized/*adverse effects
Antibodies, Monoclonal, Humanized/*therapeutic use
Dermatologic Agents/*adverse effects
Psoriasis/*drug therapy
Female ; Humans ; Middle Aged ; Psoriasis/chemically induced

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 27.

Tytuł:

Isotretinoin on TikTok™: misinformation getting under our skin.

Autorzy:

Chen MKY; Department of Dermatology, Liverpool Hospital, Liverpool, NSW, Australia.; South Western Sydney Clinical School, University of New South Wales, Liverpool, NSW, Australia.
Garden F; South Western Sydney Clinical School, University of New South Wales, Liverpool, NSW, Australia.; Ingham Institute for Applied Medical Research, Liverpool, NSW, Australia.
Sebaratnam DF; Department of Dermatology, Liverpool Hospital, Liverpool, NSW, Australia.; South Western Sydney Clinical School, University of New South Wales, Liverpool, NSW, Australia.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Dec; Vol. 46 (8), pp. 1606-1607. Date of Electronic Publication: 2021 Jul 23.

Typ publikacji:

Letter

MeSH Terms:

Communication*
Social Media*
Dermatologic Agents/*therapeutic use
Isotretinoin/*therapeutic use
Cross-Sectional Studies ; Dermatologic Agents/adverse effects ; Humans ; Isotretinoin/adverse effects ; Patient Education as Topic/methods ; Video Recording

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 28.

Tytuł:

What's new in atopic eczema? An analysis of systematic reviews published in 2019. Part 2: treatment.

Autorzy:

Marrouche N; Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK.
Lancaster N; Research and Development, Barnsley Hospital NHS Foundation Trust, Barnsley, UK.
Grindlay DJC; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Rogers NK; Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Olabi B; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Oct; Vol. 46 (7), pp. 1211-1215. Date of Electronic Publication: 2021 Aug 18.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Dermatitis, Atopic/*drug therapy
Dermatologic Agents/*therapeutic use
Administration, Topical ; Adrenal Cortex Hormones/administration & dosage ; Dermatitis, Atopic/therapy ; Emollients/therapeutic use ; Histamine Antagonists/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; Phosphodiesterase 4 Inhibitors/therapeutic use ; Systematic Reviews as Topic

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 29.

Tytuł:

Safety of the combined use of methotrexate and acitretin in a dermatology hospital setting.

Autorzy:

Andersson NW; Department of Dermatology and Allergy, Gentofte and Herlev Hospital, Hellerup, Denmark.; Department of Epidemiology Research, Statens Serum Institut, Copenhagen S, Denmark.
Simonsen AB; Department of Dermatology and Allergy, Gentofte and Herlev Hospital, Hellerup, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Thomsen SF; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Dermatology, Bispebjerg Hospital & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Zachariae C; Department of Dermatology and Allergy, Gentofte and Herlev Hospital, Hellerup, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Aug; Vol. 46 (6), pp. 1103-1105. Date of Electronic Publication: 2021 Mar 22.

Typ publikacji:

Letter

MeSH Terms:

Acitretin/*adverse effects
Chemical and Drug Induced Liver Injury/*etiology
Dermatologic Agents/*adverse effects
Methotrexate/*adverse effects
Skin Diseases/*drug therapy
Acitretin/administration & dosage ; Adult ; Aged ; Dermatologic Agents/administration & dosage ; Drug Therapy, Combination ; Female ; Humans ; Male ; Methotrexate/administration & dosage ; Middle Aged

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 30.

Tytuł:

Successful treatment of severe blepharitis in a patient with atopic dermatitis by topical delgocitinib.

Autorzy:

Dainichi T; Department of Dermatology, Kagawa University Faculty of Medicine, Kagawa, Japan.
Kaku Y; Department of Dermatology, Kagawa University Faculty of Medicine, Kagawa, Japan.
Izumi M; Department of Dermatology, Kagawa University Faculty of Medicine, Kagawa, Japan.
Kataoka K; Department of Dermatology, Kagawa University Faculty of Medicine, Kagawa, Japan.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Aug; Vol. 46 (6), pp. 1119-1120. Date of Electronic Publication: 2021 May 02.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Blepharitis/*complications
Blepharitis/*drug therapy
Dermatitis, Atopic/*complications
Dermatologic Agents/*administration & dosage
Janus Kinase 1/*antagonists & inhibitors
Pyrroles/*administration & dosage
Administration, Topical ; Humans ; Male ; Treatment Outcome ; Young Adult

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 31.

Tytuł:

Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case series.

Autorzy:

Bosma AL; Department of Dermatology, Amsterdam University Medical Centers (Amsterdam UMC), location Academic Medical Center, Amsterdam Public Health, Immunity and Infections, University of Amsterdam, Amsterdam, The Netherlands.
Gerbens LAA; Department of Dermatology, Amsterdam University Medical Centers (Amsterdam UMC), location Academic Medical Center, Amsterdam Public Health, Immunity and Infections, University of Amsterdam, Amsterdam, The Netherlands.
Middelkamp-Hup MA; Department of Dermatology, Amsterdam University Medical Centers (Amsterdam UMC), location Academic Medical Center, Amsterdam Public Health, Immunity and Infections, University of Amsterdam, Amsterdam, The Netherlands.
Spuls PI; Department of Dermatology, Amsterdam University Medical Centers (Amsterdam UMC), location Academic Medical Center, Amsterdam Public Health, Immunity and Infections, University of Amsterdam, Amsterdam, The Netherlands.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Aug; Vol. 46 (6), pp. 1089-1092. Date of Electronic Publication: 2021 Jun 04.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Fertilization*
Antibodies, Monoclonal, Humanized/*therapeutic use
Dermatitis, Atopic/*drug therapy
Dermatologic Agents/*therapeutic use
Adult ; Female ; Humans ; Lactation ; Male ; Pregnancy ; Pregnancy Outcome ; Withholding Treatment

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 32.

Tytuł:

Transgender issues in dermatology.

Autorzy:

Roche D; Department of Dermatology, Tallaght University Hospital, Dublin, Ireland.
Murray G; Department of Dermatology, Tallaght University Hospital, Dublin, Ireland.
Connolly M; Department of Dermatology, Tallaght University Hospital, Dublin, Ireland.
Tobin AM; Department of Dermatology, Tallaght University Hospital, Dublin, Ireland.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Aug; Vol. 46 (6), pp. 1137-1138. Date of Electronic Publication: 2021 Mar 05.

Typ publikacji:

Journal Article; Personal Narrative

MeSH Terms:

Confidentiality*
Professional-Patient Relations*
Acne Vulgaris/*drug therapy
Dermatologic Agents/*therapeutic use
Isotretinoin/*therapeutic use
Transgender Persons/*psychology
Humans ; Psychological Distress ; Testosterone/therapeutic use

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 33.

Tytuł:

TikTok™, teens and isotretinoin: recommendations for identifying trending acne-related content on the world's most popular social media platform.

Autorzy:

Zheng DX; Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Ning AY; Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Levoska MA; Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Xiang L; Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Wong C; Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Scott JF; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Aug; Vol. 46 (6), pp. 1129-1130. Date of Electronic Publication: 2021 May 15.

Typ publikacji:

Letter

MeSH Terms:

Social Media*
Acne Vulgaris/*drug therapy
Dermatologic Agents/*therapeutic use
Isotretinoin/*therapeutic use
Patient Education as Topic/*methods
Adolescent ; Communication ; Dermatologists ; Humans ; Information Dissemination ; Physician's Role

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 34.

Tytuł:

Tofacitinib for the treatment of refractory pyoderma gangrenosum.

Autorzy:

Orfaly VE; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
Kovalenko I; Department of Dermatology, Central State Medical Academy, Moscow, Russia.
Tolkachjov SN; Department of Mohs Micrographic and Reconstructive Surgery, Epiphany Dermatology, Austin, TX, USA.
Ortega-Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
Nunley JR; Department of Dermatology, Virginia Commonwealth University, Richmond, VA, USA.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Aug; Vol. 46 (6), pp. 1082-1085. Date of Electronic Publication: 2021 May 29.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Dermatologic Agents/*therapeutic use
Piperidines/*therapeutic use
Protein Kinase Inhibitors/*therapeutic use
Pyoderma Gangrenosum/*drug therapy
Pyrimidines/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Inflammatory Bowel Diseases/complications ; Leg Dermatoses/drug therapy ; Leg Dermatoses/pathology ; Male ; Middle Aged ; Pyoderma Gangrenosum/complications ; Pyoderma Gangrenosum/pathology ; Surgical Stomas/pathology ; Treatment Outcome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 35.

Tytuł:

Narrowband ultraviolet B phototherapy is associated with a reduction in topical corticosteroid and clinical improvement in atopic dermatitis: a historical inception cohort study.

Autorzy:

Choi JY; University of Dundee, Medical School, Dundee, UK.
Owusu-Ayim M; University of Dundee, Medical School, Dundee, UK.
Dawe R; University of Dundee, Medical School, Dundee, UK.; National Managed Clinical Network for Phototherapy (Photonet), NHS Tayside, UK.
Ibbotson S; University of Dundee, Medical School, Dundee, UK.
Fleming C; University of Dundee, Medical School, Dundee, UK.
Foerster J; University of Dundee, Medical School, Dundee, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Aug; Vol. 46 (6), pp. 1067-1074. Date of Electronic Publication: 2021 May 21.

Typ publikacji:

Journal Article; Multicenter Study

MeSH Terms:

Ultraviolet Therapy*
Adrenal Cortex Hormones/*administration & dosage
Dermatitis, Atopic/*drug therapy
Dermatitis, Atopic/*radiotherapy
Dermatologic Agents/*administration & dosage
Administration, Cutaneous ; Administration, Oral ; Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Histamine Antagonists/administration & dosage ; Humans ; Infant ; Infant, Newborn ; Male ; Prospective Studies ; Retrospective Studies ; Treatment Outcome ; Young Adult

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 36.

Tytuł:

Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.

Autorzy:

Paolino A; Departments of, Dermatology, King's College Hospital, London, UK.
Galloway J; Rheumatology, King's College Hospital, London, UK.
Birring S; Respiratory Medicine, King's College Hospital, London, UK.
Brex P; Neurology, King's College Hospital, London, UK.
Larkin G; Ophthalmology, King's College Hospital, London, UK.
Patel A; Respiratory Medicine, King's College Hospital, London, UK.
Sado D; Cardiology, King's College Hospital, London, UK.
Murgatroyd F; Cardiology, King's College Hospital, London, UK.
Walsh S; Departments of, Dermatology, King's College Hospital, London, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Aug; Vol. 46 (6), pp. 1038-1045. Date of Electronic Publication: 2021 Apr 22.

Typ publikacji:

Journal Article

MeSH Terms:

Dermatologic Agents/*therapeutic use
Sarcoidosis/*drug therapy
Sarcoidosis/*pathology
Skin Diseases/*drug therapy
Skin Diseases/*pathology
Adrenal Cortex Hormones/therapeutic use ; Adult ; Aged ; Azathioprine/therapeutic use ; Clinical Protocols ; Female ; Humans ; Hydroxychloroquine/therapeutic use ; Interleukin-12/antagonists & inhibitors ; Interleukin-23/antagonists & inhibitors ; Male ; Methotrexate/therapeutic use ; Middle Aged ; Mycophenolic Acid/therapeutic use ; Phenotype ; Prospective Studies ; Quinacrine/therapeutic use ; Referral and Consultation ; Remission Induction ; Tertiary Care Centers ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Young Adult

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 37.

Tytuł:

Brodalumab-induced subacute cutaneous lupus erythematosus.

Autorzy:

Ang E; Department of Dermatology, University Hospital of Wales, Cardiff, UK.
Hadjieconomou S; Department of Dermatology, University Hospital of Wales, Cardiff, UK.
Kalavala M; Department of Dermatology, University Hospital of Wales, Cardiff, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Jul; Vol. 46 (5), pp. 926-927. Date of Electronic Publication: 2021 Mar 09.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Antibodies, Monoclonal, Humanized/*adverse effects
Dermatologic Agents/*adverse effects
Drug Eruptions/*etiology
Lupus Erythematosus, Cutaneous/*chemically induced
Humans ; Male ; Middle Aged

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 38.

Tytuł:

Inflammatory linear verrucous epidermal naevus successfully treated with a combination of triple topical agents (corticosteroid, calcipotriol and 20% urea).

Autorzy:

Hong JK; Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.
Han HS; Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.
Yoo KH; Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Jul; Vol. 46 (5), pp. 940-942. Date of Electronic Publication: 2021 Mar 15.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Calcitriol/*analogs & derivatives
Dermatologic Agents/*administration & dosage
Nevus, Sebaceous of Jadassohn/*drug therapy
Urea/*administration & dosage
Administration, Topical ; Adolescent ; Calcitriol/administration & dosage ; Drug Combinations ; Humans ; Male ; Remission Induction

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 39.

Tytuł:

Successful treatment with oral hydroxychloroquine of seborrhoeic dermatitis in a patient with AIDS.

Autorzy:

Hu YB; Department of Dermatology, The Third Hospital of Hangzhou Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Song XZ; Department of Dermatology, The Third People's Hospital of Hangzhou, Hangzhou, China.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Apr; Vol. 46 (3), pp. 567-568. Date of Electronic Publication: 2020 Oct 31.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Acquired Immunodeficiency Syndrome/*complications
Anti-Inflammatory Agents/*therapeutic use
Dermatitis, Seborrheic/*complications
Dermatitis, Seborrheic/*drug therapy
Dermatologic Agents/*therapeutic use
Hydroxychloroquine/*therapeutic use
Administration, Oral ; Anti-Inflammatory Agents/administration & dosage ; Dermatologic Agents/administration & dosage ; Humans ; Hydroxychloroquine/administration & dosage ; Male ; Young Adult

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 40.

Tytuł:

Diagnosis and management of morphoea in children: an overview.

Autorzy:

Weibel L; Paediatric Skin Center, Paediatric Dermatology Department, University Children's Hospital Zurich, Zurich, Switzerland.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Apr; Vol. 46 (3), pp. 487-494. Date of Electronic Publication: 2021 Mar 10.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Dermatologic Agents/*therapeutic use
Scleroderma, Localized/*diagnosis
Scleroderma, Localized/*drug therapy
Abatacept/therapeutic use ; Adrenal Cortex Hormones/therapeutic use ; Child ; Early Diagnosis ; Humans ; Methotrexate/therapeutic use ; Mycophenolic Acid/therapeutic use ; Recurrence ; Scleroderma, Localized/pathology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 41.

Tytuł:

Successful treatment of acquired cutis laxa with urticarial eruption by diphenyl sulfone.

Autorzy:

Zheng BQ; Shishi General Hospital, Fujian, China.
Yan YL; Dermatology Hospital, Southern Medical University, Guangdong, China.
Ou M; Dermatology Hospital, Southern Medical University, Guangdong, China.
Wang XH; Dermatology Hospital, Southern Medical University, Guangdong, China.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Apr; Vol. 46 (3), pp. 599-603. Date of Electronic Publication: 2020 Oct 15.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Cutis Laxa/*drug therapy
Dapsone/*therapeutic use
Dermatologic Agents/*therapeutic use
Urticaria/*drug therapy
Adult ; Cutis Laxa/pathology ; Drug Administration Schedule ; Female ; Humans ; Urticaria/pathology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 42.

Tytuł:

Effect of isotretinoin on glucose metabolism in patients with diabetes.

Autorzy:

Connolly A; Department of Dermatology, King's College Hospital, NHS Foundation Trust, London, UK.
Walsh S; Department of Dermatology, King's College Hospital, NHS Foundation Trust, London, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Apr; Vol. 46 (3), pp. 549-550. Date of Electronic Publication: 2020 Oct 22.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Insulin Resistance*
Acne Vulgaris/*drug therapy
Dermatologic Agents/*adverse effects
Diabetes Mellitus, Type 1/*blood
Insulin/*blood
Isotretinoin/*adverse effects
Acne Vulgaris/complications ; Blood Glucose/metabolism ; Diabetes Mellitus, Type 1/complications ; Female ; Humans ; Young Adult

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 43.

Tytuł:

Alitretinoin for prurigo nodularis.

Autorzy:

Maqbool T; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.
Kraft JN; Lynde Dermatology, Markham, ON, Canada.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Mar; Vol. 46 (2), pp. 362-363. Date of Electronic Publication: 2020 Oct 10.

Typ publikacji:

Letter

MeSH Terms:

Alitretinoin/*therapeutic use
Dermatologic Agents/*therapeutic use
Prurigo/*drug therapy
Humans ; Male ; Middle Aged

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 44.

Tytuł:

Management of nail psoriasis.

Autorzy:

Thomas L; Department of Dermatology, The James Cook University Hospital, Middlesbrough, UK.
Azad J; Department of Dermatology, The James Cook University Hospital, Middlesbrough, UK.
Takwale A; Department of Dermatology, Gloucestershire Hospitals NHS Foundation Trust, Gloucestershire, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Jan; Vol. 46 (1), pp. 3-8. Date of Electronic Publication: 2020 Aug 02.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Dermatologic Agents/*therapeutic use
Nail Diseases/*drug therapy
Psoriasis/*drug therapy
Administration, Topical ; Child ; Humans ; Immunosuppressive Agents/therapeutic use ; Methotrexate/therapeutic use ; Nail Diseases/diagnosis ; Nails/pathology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 45.

Tytuł:

Inflammatory nail conditions. Part 1: nail changes in psoriasis.

Autorzy:

Yesudian PD; Department of Dermatology, Wrexham Maelor Hospital, Wrexham, UK.
de Berker DAR; Department of Dermatology, Bristol Royal Infirmary, Bristol, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Jan; Vol. 46 (1), pp. 9-15. Date of Electronic Publication: 2020 Jul 31.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Dermatologic Agents/*administration & dosage
Glucocorticoids/*administration & dosage
Nail Diseases/*etiology
Nails/*pathology
Psoriasis/*complications
Administration, Topical ; Dermoscopy ; Humans ; Injections, Intralesional ; Methotrexate/therapeutic use ; Nail Diseases/diagnosis ; Nail Diseases/drug therapy ; Psoriasis/pathology ; Steroids/administration & dosage ; Triamcinolone/administration & dosage

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 46.

Tytuł:

Treating cystic and conglobate acne with 13-cis-retinoic acid.

Autorzy:

Yesudian PD; Department of Dermatology, Wrexham Maelor Hospital, Wrexham, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2020 Dec; Vol. 45 (8), pp. 1109-1110. Date of Electronic Publication: 2020 Aug 13.

Typ publikacji:

Historical Article; Journal Article

MeSH Terms:

Acne Conglobata/*drug therapy
Acne Vulgaris/*drug therapy
Dermatologic Agents/*therapeutic use
Isotretinoin/*therapeutic use
Acne Conglobata/pathology ; Acne Vulgaris/pathology ; Animals ; Cysts/pathology ; Dermatologic Agents/administration & dosage ; Dermatologic Agents/history ; History, 20th Century ; Humans ; Isotretinoin/administration & dosage ; Isotretinoin/history ; Mice ; Models, Animal ; Papilloma/chemically induced ; Papilloma/drug therapy ; Placebo Effect ; Skin Neoplasms/prevention & control ; Vitamin A/chemistry

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 47.

Tytuł:

Four-year data from use of the nut and soya allergy testing protocol before treatment with isotretinoin and alitretinoin.

Autorzy:

Alden K; Departments of, Department of, Dermatology, University Hospital of Wales, Cardiff, UK.
Chowdhury MMU; Departments of, Department of, Dermatology, University Hospital of Wales, Cardiff, UK.
Williams PE; Department of, Immunology, University Hospital of Wales, Cardiff, UK.
Kalavala M; Departments of, Department of, Dermatology, University Hospital of Wales, Cardiff, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2020 Jul; Vol. 45 (5), pp. 627-629. Date of Electronic Publication: 2020 May 02.

Typ publikacji:

Letter

MeSH Terms:

Alitretinoin/*adverse effects
Dermatologic Agents/*adverse effects
Food Hypersensitivity/*diagnosis
Isotretinoin/*adverse effects
Nut Hypersensitivity/*diagnosis
Glycine max/*adverse effects
Anacardium/adverse effects ; Contraindications, Drug ; Cross Reactions ; Humans ; Skin Tests

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 48.

Tytuł:

Depression in transgender adolescents under treatment with isotretinoin.

Autorzy:

Campos-Muñoz L; Departments of, Department of, Dermatology, Hospital Clínico San Carlos, Madrid, Spain.
López-De Lara D; Department of, Pediatrics, Hospital Clínico San Carlos, Madrid, Spain.
Conde-Taboada A; Departments of, Department of, Dermatology, Hospital Clínico San Carlos, Madrid, Spain.
Fueyo Casado A; Departments of, Department of, Dermatology, Hospital Clínico San Carlos, Madrid, Spain.
López-Bran E; Departments of, Department of, Dermatology, Hospital Clínico San Carlos, Madrid, Spain.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2020 Jul; Vol. 45 (5), pp. 615-616. Date of Electronic Publication: 2020 Apr 10.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Transgender Persons*
Acne Vulgaris/*drug therapy
Depressive Disorder/*chemically induced
Dermatologic Agents/*adverse effects
Isotretinoin/*adverse effects
Adolescent ; Depressive Disorder/drug therapy ; Dermatologic Agents/therapeutic use ; Humans ; Isotretinoin/therapeutic use ; Male ; Suicide, Attempted

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 49.

Tytuł:

Extragenital lichen sclerosus successfully treated by topical maxacalcitol/betamethasone butyrate propionate.

Autorzy:

Mori S; Department of Dermatology, Iwate Medical University School of Medicine, Morioka, Iwate, Japan.; Department of Stem Cell Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Tamai K; Department of Stem Cell Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Amano H; Department of Dermatology, Iwate Medical University School of Medicine, Morioka, Iwate, Japan.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2020 Jul; Vol. 45 (5), pp. 629-630. Date of Electronic Publication: 2020 May 02.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Betamethasone/*analogs & derivatives
Calcitriol/*analogs & derivatives
Dermatologic Agents/*administration & dosage
Lichen Sclerosus et Atrophicus/*drug therapy
Administration, Topical ; Betamethasone/administration & dosage ; Calcitriol/administration & dosage ; Drug Combinations ; Female ; Humans ; Lichen Sclerosus et Atrophicus/pathology ; Middle Aged ; Neck/pathology ; Skin/pathology

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 50.

Tytuł:

Isotretinoin and mental health: a survey of Scottish Dermatology Society members.

Autorzy:

Affleck AG; Department of Dermatology, Ninewells Hospital, NHS Tayside, Dundee, UK.
Stewart AM; Liaison Psychiatry, Carseview Centre, Dundee, UK.
Nicolson J; University of Dundee School of Medicine, Dundee, UK.
Salmon N; Department of Dermatology, Ninewells Hospital, NHS Tayside, Dundee, UK.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2020 Jun; Vol. 45 (4), pp. 476-478. Date of Electronic Publication: 2019 Dec 16.

Typ publikacji:

Letter

MeSH Terms:

Dermatologic Agents/*adverse effects
Isotretinoin/*adverse effects
Mental Health/*statistics & numerical data
Mood Disorders/*chemically induced
Acne Vulgaris/drug therapy ; Acne Vulgaris/psychology ; Depression/chemically induced ; Depression/epidemiology ; Depression/psychology ; Dermatologists/statistics & numerical data ; Dermatology/organization & administration ; Humans ; Mood Disorders/epidemiology ; Mood Disorders/psychology ; Prevalence ; Risk Factors ; Scotland/epidemiology ; Suicide, Completed/statistics & numerical data ; Surveys and Questionnaires

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły